Question:

Which of the following drugs is NOT used in the treatment of Alzheimer's disease?

Show Hint

Alzheimer's regimen summary: - Acetylcholinesterase blockers: Donepezil, Galantamine, Rivastigmine. - NMDA antagonist: Memantine. - Anti-amyloid monoclonal antibody: Aducanumab.
Updated On: Jul 4, 2026
  • Aducanumab
  • Carbamazepine
  • Donepezil
  • Galantamine
Show Solution
collegedunia
Verified By Collegedunia

The Correct Option is B

Solution and Explanation

Concept: Alzheimer's disease is a progressive neurodegenerative disorder characterized pathologically by extracellular amyloid-beta ($\beta$-amyloid) plaques and intracellular neurofibrillary tau tangles, alongside a severe loss of central cholinergic neurons in the basal forebrain. Therapeutic management focuses on two strategies:
Reversible Acetylcholinesterase Inhibitors: Boost acetylcholine levels in the synaptic cleft (e.g., Donepezil, Galantamine, Rivastigmine).
Monoclonal Antibodies targeting Amyloid: Clear $\beta$-amyloid deposits (e.g., Aducanumab, Lecanemab).

Step 1:
Evaluate the role of Carbamazepine.
Carbamazepine is a sodium channel blocker widely categorized as an antiepileptic drug (anticonvulsant) used to manage generalized tonic-clonic seizures, partial seizures, and neuropathic pain conditions like trigeminal neuralgia. It does not target Alzheimer's pathology, making it the correct choice.
Was this answer helpful?
0
0